1. Involvement of phospholipase A2 in gynecological cancer
   Cornelia Amalinei et al, 2023, Phospholipases in Physiology and Pathology CrossRef
2. Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation
   Matthew Benesch et al, 2018, Cancers CrossRef
3. Models including plasma levels of sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer
   Tamara Knific et al, 2018, The Journal of Steroid Biochemistry and Molecular Biology CrossRef
4. A calcium-dependent phospholipase A2 (cPLA2) expression is regulated by MIG-6 during endometrial tumorigenesis
   Hanna E. Teasley et al, 2019, Biochemical and Biophysical Research Communications CrossRef
5. Altered expression of lysophosphatidic acid receptors, in association with the synthesis of estrogens and androgens in type 1 endometrial cancer biology
   Tomasz Wasniewski et al, 2018, Gynecological Endocrinology CrossRef
6. ATX‑LPA axis facilitates estrogen‑induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway
   Guo Zhang et al, 2018, Molecular Medicine Reports CrossRef
7. Lipid metabolism and Calcium signaling in epithelial ovarian cancer
   Sana Kouba et al, 2019, Cell Calcium CrossRef
8. Identification and functional analyses of differentially expressed metabolites in early stage endometrial carcinoma
   Kun Shi et al, 2018, Cancer Science CrossRef
9. Analysis of glycero-lysophospholipids in gastric cancerous ascites
   Shigenobu Emoto et al, 2017, Journal of Lipid Research CrossRef
10. Autotaxin is a novel molecular identifier of type I endometrial cancer
    Antonio Mazzocca et al, 2018, Medical Oncology CrossRef
11. Metabolomics in endometrial cancer diagnosis: A systematic review
    Antonio Raffone et al, 2020, Acta Obstetricia et Gynecologica Scandinavica CrossRef